279. Deputy John Lahart asked the Minister for Health the reason persons with multiple sclerosis have access to new medicines within weeks or months in many European countries but patients here can wait over four years for new medicines to be made available (details supplied); the reason for slower approval for new medicines here; the steps he is taking to ensure access is expedited; and the date same will be achieved. [48648/19]

Summary

279. Deputy John Lahart asked the Minister for Health the reason persons with multiple sclerosis have access to new medicines within weeks or months in many European countries but patients here can wait over four years for new medicines to be made available (details supplied); the reason for slower approval for new medicines here; the steps he is taking to ensure access is expedited; and the date same will be achieved. [48648/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Licensing

  xml · EN · 26 November 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.